Atara Biotherapeutics
ATRA
ATRA
154 hedge funds and large institutions have $376M invested in Atara Biotherapeutics in 2022 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 63 increasing their positions, 28 reducing their positions, and 20 closing their positions.
Holders
154
Holders Change
+20
Holders Change %
+14.93%
% of All Funds
2.66%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
40
Increased
63
Reduced
28
Closed
20
Calls
$114K
Puts
$342K
Net Calls
-$228K
Net Calls Change
-$2.14M
Top Buyers
| 1 |
WA
1
Wasatch Advisors
Salt Lake City,
Utah
|
$30.8M |
| 2 |
2
D.E. Shaw & Co
New York
|
$10.3M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$30.6M |
| 4 |
4
Goldman Sachs
New York
|
$18M |
| 5 |
5
Acadian Asset Management
Boston,
Massachusetts
|
$3.61M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
176
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $0 | 2 | +2 | New |
|
|
PA
177
Parallel Advisors
San Francisco,
California
| $0 | 4 | +4 | New |
|